IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $731,697 | -7.4% | 75,981 | +2.3% | 0.01% | 0.0% |
| Q2 2023 | $789,892 | +0.9% | 74,238 | -0.2% | 0.01% | 0.0% |
| Q1 2023 | $782,825 | -14.7% | 74,413 | +0.5% | 0.01% | -16.7% |
| Q4 2022 | $917,579 | +18.7% | 74,058 | -0.8% | 0.01% | 0.0% |
| Q3 2022 | $773,000 | -10.9% | 74,624 | -0.9% | 0.01% | 0.0% |
| Q2 2022 | $868,000 | -5.3% | 75,319 | +3.3% | 0.01% | +20.0% |
| Q1 2022 | $917,000 | +0.8% | 72,878 | -6.6% | 0.01% | 0.0% |
| Q4 2021 | $910,000 | -12.3% | 78,007 | -1.9% | 0.01% | -16.7% |
| Q3 2021 | $1,038,000 | -1.0% | 79,515 | -2.3% | 0.01% | +50.0% |
| Q2 2021 | $1,048,000 | -23.8% | 81,404 | -33.8% | 0.00% | -20.0% |
| Q1 2021 | $1,375,000 | -4.7% | 122,973 | -2.9% | 0.01% | 0.0% |
| Q4 2020 | $1,443,000 | +68.2% | 126,704 | +32.8% | 0.01% | +25.0% |
| Q3 2020 | $858,000 | -14.8% | 95,422 | -2.2% | 0.00% | -20.0% |
| Q2 2020 | $1,007,000 | +7.9% | 97,592 | +5.5% | 0.01% | 0.0% |
| Q1 2020 | $933,000 | -27.2% | 92,491 | -3.9% | 0.01% | 0.0% |
| Q4 2019 | $1,281,000 | +53.8% | 96,237 | -0.8% | 0.01% | +66.7% |
| Q3 2019 | $833,000 | -22.1% | 97,046 | -0.7% | 0.00% | -25.0% |
| Q2 2019 | $1,069,000 | -11.9% | 97,723 | +8.9% | 0.00% | -20.0% |
| Q1 2019 | $1,214,000 | +26.5% | 89,710 | -3.1% | 0.01% | +25.0% |
| Q4 2018 | $960,000 | -43.4% | 92,618 | +0.8% | 0.00% | -33.3% |
| Q3 2018 | $1,697,000 | -1.7% | 91,906 | +1.8% | 0.01% | 0.0% |
| Q2 2018 | $1,726,000 | +30.0% | 90,250 | +4.8% | 0.01% | +20.0% |
| Q1 2018 | $1,328,000 | -2.4% | 86,090 | -5.1% | 0.01% | +25.0% |
| Q4 2017 | $1,360,000 | -4.5% | 90,721 | +0.5% | 0.00% | -20.0% |
| Q3 2017 | $1,424,000 | -9.7% | 90,291 | +8.1% | 0.01% | -16.7% |
| Q2 2017 | $1,577,000 | +18.0% | 83,540 | +6.6% | 0.01% | +20.0% |
| Q1 2017 | $1,337,000 | +17.5% | 78,346 | +5.3% | 0.01% | +25.0% |
| Q4 2016 | $1,138,000 | -99.9% | 74,406 | -0.3% | 0.00% | -20.0% |
| Q3 2016 | $1,184,616,000 | +21.6% | 74,598 | +0.2% | 0.01% | +25.0% |
| Q2 2016 | $973,878,000 | +20.7% | 74,484 | +1.0% | 0.00% | +33.3% |
| Q1 2016 | $807,000,000 | -5.6% | 73,762 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $855,000,000 | +110939.0% | 73,762 | -0.2% | 0.00% | +33.3% |
| Q3 2015 | $770,000 | -99.9% | 73,890 | +0.1% | 0.00% | -25.0% |
| Q2 2015 | $890,052,000 | -26.0% | 73,802 | -1.8% | 0.00% | -20.0% |
| Q1 2015 | $1,202,224,000 | +4.4% | 75,139 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $1,151,129,000 | +11.6% | 75,139 | -5.6% | 0.01% | 0.0% |
| Q3 2014 | $1,031,179,000 | -13.9% | 79,597 | +1.8% | 0.01% | 0.0% |
| Q2 2014 | $1,198,346,000 | +35.4% | 78,170 | +8.9% | 0.01% | +25.0% |
| Q1 2014 | $884,736,000 | +23.4% | 71,813 | +16.3% | 0.00% | +33.3% |
| Q4 2013 | $716,964,000 | -3.0% | 61,754 | -1.0% | 0.00% | -25.0% |
| Q3 2013 | $739,132,000 | +27.8% | 62,374 | +7.3% | 0.00% | +33.3% |
| Q2 2013 | $578,222,000 | – | 58,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |